Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy and Safety of Diamyd® in Children and Adolescents With Type 1 Diabetes

This study has been completed.
Sponsor:
Information provided by:
Diamyd Therapeutics AB
ClinicalTrials.gov Identifier:
NCT00435981
First received: February 15, 2007
Last updated: January 29, 2008
Last verified: January 2008